Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

News SummaryMost relevantAll newsSector news 

Bristol Myers Squibb : Assigned Patent

07/25/2014 | 07:18am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., July 25 -- Bristol-Myers Squibb, Princeton, New Jersey, has been assigned a patent (8,785,398) developed by four co-inventors for the "methods of treatment using CTLA4 mutant molecules." The co-inventors are Robert James Peach, San Diego, Joseph Naemura, Bellevue, Washington, Peter S. Linsley, Seattle, and Jurgen Bajorath, Bonn, Germany.

The patent application was filed on Oct. 20, 2011 (13/277,425). The full-text of the patent can be found at,85,398.PN.&OS=PN/87,85,398&RS=PN/87,85,398

Written by Sudarshan Harpal; edited by Jaya Anand.


(c) 2014 Targeted News Service

React to this article
04:53a Otsuka and Bristol-Myers Squibb Announce a Change in Contract Regarding Colla..
02/27 BRISTOL MYERS SQUIBB : Other Events, Financial Statements and Exhibits (form 8-K..
02/27 BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Biologics Licen..
02/26 BRISTOL MYERS SQUIBB : ALLY Trial Demonstrates 97% Hepatitis C Cure Rates Among ..
02/26 BRISTOL MYERS SQUIBB : Study of Next-Generation Investigational HIV-1 Maturation..
02/26 BRISTOL MYERS SQUIBB : An Application for the Trademark "DESYREL" Has Been Filed..
02/25 BRISTOL MYERS SQUIBB : Research Conducted at Bristol-Myers Squibb Has Provided N..
02/25 BRISTOL MYERS SQUIBB : Findings in General Science Reported from Bristol-Myers S..
02/25 BRISTOL MYERS SQUIBB : An Application for the Trademark "NURSETTE" Has Been File..
02/25 BRISTOL MYERS SQUIBB : New Antiretrovirals Data Have Been Reported by Researcher..
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes